Key result
Amiodarone pulmonary toxicity has protean features, and neither foamy alveolar macrophages nor lamellated inclusions reliably distinguish toxic from nontoxic patients.
Why the study?
Do specific pathologic or radiographic features reliably distinguish amiodarone pulmonary toxicity from non-toxic amiodarone use?
Case-Control (n=20)
Do specific pathologic or radiographic features reliably distinguish amiodarone pulmonary toxicity from non-toxic amiodarone use?
Pathologic findings such as foamy alveolar macrophages and lamellated cytoplasmic inclusions are common in patients taking amiodarone but do not reliably distinguish those with pulmonary toxicity from those without.
Answers are grounded in this paper and cite their sources.
Clinicians should not rely on these findings to diagnose amiodarone toxicity; leaves open the need for validated distinguishing criteria.
• We have studied 15 patients with amiodarone pulmonary toxicity and compared them with five amiodarone patients without evidence of toxic effect. Six of 15 patients who had toxic reactions presented with an acute illness that resembled an infectious disease. While diffuse interstitial disease was frequent on chest roentgenogram, seven of 15 had airspace opacities, and five had well-localized infiltrates. Physiologic changes were not uniformly found. An interstitial pneumonia with foamy alveolar macrophages was the most common pathologic finding. Foamy macrophages were also present in three of five nontoxic patients. Three of three patients who had toxic reactions, and two of five patients without toxic reactions had lamellated inclusion bodies by electron microscopy. We conclude that all features of amiodarone toxicity are protean, and it may mimic infectious diseases. While pathologic changes are often characteristic, neither foamy alveolar macrophages nor lamellated cytoplasmic inclusions reliably distinguish toxic from nontoxic patients. (Arch Intern Med1987;147:50-55)
No takes yet. Share an insight, caveat, or question.
John I. Kennedy (1987) conducted a case-control in Amiodarone pulmonary toxicity (n=20). Amiodarone pulmonary toxicity vs. Amiodarone patients without evidence of toxic effect was evaluated on Pathologic features (foamy alveolar macrophages and lamellated inclusion bodies). Amiodarone pulmonary toxicity has protean features, and neither foamy alveolar macrophages nor lamellated inclusions reliably distinguish toxic from nontoxic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: